
Sign up to save your podcasts
Or


EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.
By cancerGRACE - H. Jack West, MD5
11 ratings
EGFR positive lung cancer patients who had seen cancer progression responded well to a new drug in an early clinical trial.

2 Listeners

0 Listeners

0 Listeners

0 Listeners

1 Listeners

0 Listeners

0 Listeners

0 Listeners

0 Listeners